Suppr超能文献

心力衰竭:糖尿病被低估的并发症。美国糖尿病协会共识报告。

Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association.

机构信息

Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.

Cardiology Division, Massachusetts General Hospital, and Cardiometabolic Trials, Baim Institute for Clinical Research, Boston, MA.

出版信息

Diabetes Care. 2022 Jul 7;45(7):1670-1690. doi: 10.2337/dci22-0014.

Abstract

Heart failure (HF) has been recognized as a common complication of diabetes, with a prevalence of up to 22% in individuals with diabetes and increasing incidence rates. Data also suggest that HF may develop in individuals with diabetes even in the absence of hypertension, coronary heart disease, or valvular heart disease and, as such, represents a major cardiovascular complication in this vulnerable population; HF may also be the first presentation of cardiovascular disease in many individuals with diabetes. Given that during the past decade, the prevalence of diabetes (particularly type 2 diabetes) has risen by 30% globally (with prevalence expected to increase further), the burden of HF on the health care system will continue to rise. The scope of this American Diabetes Association consensus report with designated representation from the American College of Cardiology is to provide clear guidance to practitioners on the best approaches for screening and diagnosing HF in individuals with diabetes or prediabetes, with the goal to ensure access to optimal, evidence-based management for all and to mitigate the risks of serious complications, leveraging prior policy statements by the American College of Cardiology and American Heart Association.

摘要

心力衰竭(HF)已被认为是糖尿病的一种常见并发症,在糖尿病患者中的患病率高达 22%,且发病率不断上升。数据还表明,即使在没有高血压、冠心病或心脏瓣膜病的情况下,糖尿病患者也可能发生心力衰竭,因此,心力衰竭是这一脆弱人群的主要心血管并发症;心力衰竭也可能是许多糖尿病患者心血管疾病的首发表现。鉴于在过去十年中,全球糖尿病(尤其是 2 型糖尿病)的患病率上升了 30%(预计患病率还将进一步上升),心力衰竭给医疗保健系统带来的负担将继续增加。美国糖尿病协会共识报告的范围,指定了来自美国心脏病学会的代表,旨在为从业者提供有关在糖尿病或糖尿病前期患者中筛查和诊断心力衰竭的最佳方法的明确指导,目标是确保所有患者都能获得最佳的、基于证据的管理,并减轻严重并发症的风险,利用美国心脏病学会和美国心脏协会之前的政策声明。

相似文献

5
Prevalence, Neurohormonal Correlates, and Prognosis of Heart Failure Stages in the Community.
JACC Heart Fail. 2016 Oct;4(10):808-815. doi: 10.1016/j.jchf.2016.05.001. Epub 2016 Jul 6.
6
Management strategies to meet the core heart failure measures for acute decompensated heart failure: a nursing perspective.
Crit Care Nurs Q. 2007 Oct-Dec;30(4):307-20. doi: 10.1097/01.CNQ.0000290364.57677.56.

引用本文的文献

1
Age-Related Characteristics of Diastolic Dysfunction in Type 2 Diabetes Patients.
J Clin Med. 2025 Aug 15;14(16):5772. doi: 10.3390/jcm14165772.
2
Diabetes-Kidney-Heart Continuum and Its Implication on Therapeutic Management.
Cureus. 2025 Jul 22;17(7):e88561. doi: 10.7759/cureus.88561. eCollection 2025 Jul.
3
Biomarkers for cardiovascular-kidney metabolic syndrome: Clinical utility in diagnosis, screening, and treatment.
Diabetes Obes Metab. 2025 Sep;27 Suppl 8(Suppl 8):3-6. doi: 10.1111/dom.70044. Epub 2025 Aug 26.
4
The retina as a window into detecting subclinical cardiovascular disease in type 2 diabetes.
Sci Rep. 2025 Jul 31;15(1):27968. doi: 10.1038/s41598-025-13468-4.
5
The Mechanical Role of YAP/TAZ in the Development of Diabetic Cardiomyopathy.
Curr Issues Mol Biol. 2025 Apr 23;47(5):297. doi: 10.3390/cimb47050297.
9
Contribution of chronic conditions to mortality: Differences by race and ethnicity.
Aging Health Res. 2025 Jun;5(2). doi: 10.1016/j.ahr.2025.100231. Epub 2025 Apr 23.
10
Impact of SGLT-2 Inhibitors on Biomarkers of Heart Failure.
Cells. 2025 Jun 18;14(12):919. doi: 10.3390/cells14120919.

本文引用的文献

1
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022.
Diabetes Care. 2022 Jan 1;45(Suppl 1):S144-S174. doi: 10.2337/dc22-S010.
2
Introduction: Standards of Medical Care in Diabetes-2022.
Diabetes Care. 2022 Jan 1;45(Suppl 1):S1-S2. doi: 10.2337/dc22-Sint.
3
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.
N Engl J Med. 2021 Dec 9;385(24):2252-2263. doi: 10.1056/NEJMoa2110956. Epub 2021 Aug 28.
4
Comparative Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors vs Sulfonylureas in Patients With Type 2 Diabetes.
JAMA Intern Med. 2021 Aug 1;181(8):1043-1053. doi: 10.1001/jamainternmed.2021.2488.
5
Dietary interventions and nutritional supplements for heart failure: a systematic appraisal and evidence map.
Eur J Heart Fail. 2021 Sep;23(9):1468-1476. doi: 10.1002/ejhf.2278. Epub 2021 Jul 8.
8
Short-term rapid weight loss induced by bariatric surgery improves ventricular ejection fraction in patients with severe obesity and heart failure.
Surg Obes Relat Dis. 2021 Sep;17(9):1616-1620. doi: 10.1016/j.soard.2021.05.004. Epub 2021 May 15.
10
Obesity and Heart Failure with Preserved Ejection Fraction.
Heart Fail Clin. 2021 Jul;17(3):345-356. doi: 10.1016/j.hfc.2021.02.003.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验